Damora Therapeutics (DMRA) Shareholder's Equity (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.83% |
| Dec 31, 2025 | 2,902.12% |
| Sep 30, 2025 | -26.90% |
| Jun 30, 2025 | -20.10% |
| Mar 31, 2025 | -13.40% |
| Dec 31, 2024 | -24.38% |
| Sep 30, 2024 | -11.25% |
| Jun 30, 2024 | -16.23% |
| Mar 31, 2024 | -12.90% |
| Dec 31, 2023 | -13.51% |
| Sep 30, 2023 | -14.46% |
| Jun 30, 2023 | -13.18% |
| Mar 31, 2023 | -18.49% |
| Dec 31, 2022 | -15.09% |
| Sep 30, 2022 | -14.50% |
| Jun 30, 2022 | -16.04% |
| Mar 31, 2022 | -13.57% |
| Dec 31, 2021 | -9.56% |
| Sep 30, 2021 | -8.35% |
| Jun 30, 2021 | -7.30% |
| Mar 31, 2021 | -7.81% |
| Dec 31, 2020 | 280.40% |
| Sep 30, 2020 | -11.13% |
| Jun 30, 2020 | -7.16% |
| Mar 31, 2020 | -8.27% |
| Dec 31, 2019 | -48.05% |